课题基金 / 基金详情

Cholesterol homeostasis in pathogenesis of DR

Cholesterol homeostasis in pathogenesis of DR
DR 发病机制中的胆固醇稳态
批准号:
10542239
负责人:
Julia V Busik
金额:
$5.05万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-09-01 至 2025-08-31

项目摘要

项目成果

Julia V Busik的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Disruptions in cholesterol homeostasis and metabolism can lead to high cholesterol concentrations in diseased tissue and the formation of cholesterol crystals (CC). CC are often overlooked in traditional histo/immunohistochemistry as the ethanol, used for tissue processing, can dissolve them. This masks CC presence and potential involvement in pathogenic mechanisms. Using Scanning Electron Microscopy (SEM) of tissues prepared without an ethanol dehydration step, we identified the presence of CC: i) in “lipid pools” between retinal pigment epithelium (RPE) and photoreceptors (PR); ii) circulating freely in diabetic murine blood; and iii) within circulating monocytes of diabetic human subjects. Since CC are very stable physiologically and are not easily amenable to dissolving in vivo, they become a source of chronic inflammation. CC are recognized by the innate immune system as foreign bodies because of their shape, firmness, and inability to be dissolved. Moreover, CC also induce inflammation via the NLRP3 inflammasome activation. These novel preliminary and published studies have led us to propose the following hypothesis (see schematic in Fig.1): Diabetes- induced disruption of i) systemic cholesterol homeostasis, ii) blood retinal barrier function; and iii) SIRT1, LXR and CYP46A1 expression alters retinal cholesterol homeostasis leading to CC formation within key locations: RPE, PR, monocytes/macrophages, and in the circulation affecting the endothelium. This CC formation results in intra- and extracellular complement activation and priming of the NLRP3 inflammasome for its activation and release of highly damaging pro-inflammatory cytokines, promoting development of DR. To test this hypothesis, we propose the following Specific Aims: Aim1: To determine the temporal changes in retinal cholesterol accumulation that lead to CC formation. Aim 2: To test the hypothesis that diabetes- induced cholesterol accumulation and CC formation in the retina and in monocytes/macrophages induces activation of intracellular and extracellular complement to trigger the NLRP3 inflammasome and IL-1β production. Aim 3: To test the hypothesis that LXR activation and direct sequestration of cholesterol by alpha-cyclodextrin can inhibit CC-induced complosome and NLRP3 inflammasome formation in the diabetic retina and in monocytes/macrophages cells, thus preventing chronic inflammation and development of DR. Impact: The successful completion of this project will result in identifying an entirely novel pathway in which CC-induced complosome and NLRP3 inflammasome formation that can be pharmacologically targeted to prevent DR.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-ceramide immunotherapy for diabetic retinopathy
  • 批准号:
    10440369
  • 项目类别:
  • 资助金额:
    $38.02万
  • 财政年份:
    2019
  • 负责人:
    Julia V Busik
  • 依托单位:
Anti-ceramide immunotherapy for diabetic retinopathy
  • 批准号:
    10200072
  • 项目类别:
  • 资助金额:
    $38.06万
  • 财政年份:
    2019
  • 负责人:
    Julia V Busik
  • 依托单位:
Ceramide-mediated mitochondrial damage in diabetic retinopathy investigated by novel microfluidic O2 sensing and bio-mimetic electrochemistry
  • 批准号:
    9904655
  • 项目类别:
  • 资助金额:
    $37.29万
  • 财政年份:
    2018
  • 负责人:
    Julia V Busik
  • 依托单位:
Ceramide-mediated mitochondrial damage in diabetic retinopathy investigated by novel microfluidic O2 sensing and bio-mimetic electrochemistry
  • 批准号:
    10132325
  • 项目类别:
  • 资助金额:
    $36.12万
  • 财政年份:
    2018
  • 负责人:
    Julia V Busik
  • 依托单位:
海外基金